Transgene - TG4001 first efficacy data presented at ESMO
At the 2019 European Society for Medical Oncology (ESMO) conference, Transgene presented the first efficacy data for TG4001 in combination with...
734 Views
Transgene - TG4001 first efficacy data presented at ESMO
At the 2019 European Society for Medical Oncology (ESMO) conference, Transgene presented the first efficacy data for TG4001 in combination with...
1.1k Views
Transgene - TG4010 and Pexa-Vec readouts to define 2019
Late-stage clinical trial readouts in 2019 will be critical to Transgene’s immunoncology (IO) aspirations and, if positive, could further its...
54 Views
Transgene - Combination strategy awaiting validation
Transgene develops virus-based product candidates for use in oncology and infectious diseases. Its five clinical products are currently in...
42 Views
Transgene - Near-term data to define long-term strategy
Transgene develops virus-based product candidates for use in oncology and infectious diseases, its five clinical products are currently in 11...
52 Views
No more insights